Rapamune (sirolimus) oral solution


Approval Status
Approved September 1999

Treatment for
To prevent organ rejection in patients receiving renal transplants

Possible similar drugs

Immune System

An oral solution of sirolimus to act as a prophylaxis to prevent organ rejection in patients that are receiving liver transplants.

Oral solution of sirolimus, 1 mg/ml.

Rapamune (sirolimus) oral solution Drug Information

The Rapamune (sirolimus) oral solution drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top